Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synovus Financial Turns To Profit In Q1 Vs Loss Last Year - Quick Facts

RELATED NEWS
Trade SNV now with 

Synovus Financial Corp. (SNV: Quote) reported net profit available to common shareholders for the first quarter of 2012 of $21.40 million or $0.024 per share versus loss of $93.70 million or $0.119 loss per diluted share reported for the corresponding first quarter of 2011.

On average, 21 analysts polled by Thomson Reuters expected the company to report $0.01 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the first quarter of 2012 declined to $220.96 million from $237.43 million in the corresponding quarter last year.

Total non-interest income, however, increased to $84.14 million from $64.16 million a year ago. Analysts estimated revenues of $287.10 million.

Click here to receive FREE breaking news email alerts for Synovus Financial and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks saw some volatility following the release of the Federal Reserve's monetary policy announcement on Wednesday but managed to end the day modestly higher. With the upward move, the Dow reached a new record closing high. President Barack Obama sought to emphasize in remarks on Wednesday that the American forces being deployed as part of the fight against the terrorist group ISIS will not have a combat mission. Republican Joni Ernst has moved into the lead in the potentially crucial Iowa Senate race, according to the results of a Quinnipiac University poll released on Wednesday. The poll found that 50 percent of likely Iowa voters would support Ernst if the election were held today, while 44 percent would vote for Democratic Rep. Bruce Braley.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.